MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • CSF biomarkers in neurodegenerative parkinsonism can distinguish between multiple system atrophy and 4-repeat tauopathies, but not between disease with Lewy bodies and multiple system atrophy

    P. Kanovsky, K. Bucilova, M. Chudackova, D. Konickova, K. Pekarova, K. Sklenarova, M. Kaiserova, S. Kurcova, M. Nevrly, J. Zapletalova, M. Strnad, K. Mensikova (Olomouc, Czech Republic)

  • Curcumin prevented electrophysiological and behavioral alterations in a rotenone model of Parkinson’s disease

    L. Darbinyan, L. Hambardzumyan, L. Manukyan, K. Simonyan, V. Sarkisian (Yerevan, Armenia)

  • Current Concepts in Physical Therapy and Rehabilitation Protocol for Camptocormia: An Unusual Case Report

    S. Calisgan, E. Calisgan, M. Ceylan, Y-E. Aktas (Manchester, United Kingdom)

  • Cycling Deep Brain Stimulation for Parkinson’s Disease

    C. França, A. Bertholo, A. Pelicheck, I. Paraguay, J. Reis, D. Barros, J. Yamamoto, A. Coelho, R. Otani, M. Reuter, R. Carra, T. Guimarães, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)

  • Data-driven identification of distinct fronto-subcortical and cortical-posterior subtypes of cognitive decline in Parkinson’s disease

    M. Grothe, M. Labrador-Espinosa, S. Jesús, F. Roldán Lora, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, SG. Coppadis, P. Martínez-Martín, J. Kulisevsky, D. Santos-García, P. Mir (Seville, Spain)

  • DaTscan striatal binding ratio dynamics in mutations carriers at risk for Parkinson’s disease: A 2-year prospective study

    A. Droby, D. Atias, H. Lerman, RM. Hutchison, L. Yahimovich, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

  • DaxibotulinumtoxinA for Injection in Adults With Upper Limb Spasticity After Stroke or Traumatic Brain Injury: A Randomized Placebo-Controlled Study (JUNIPER)

    A. Patel, M. Munin, Z. Ayyoub, G. Francisco, T. Gross, R. Rubio, J. Kesslak (Lee's Summit, USA)

  • DBS Experience In A Pediatric Neurowilson Case

    S. Bozkaya Yilmaz, N. Olgaç Dündar, G. Basarir, P. Gencpinar, A. Ersen (Izmir, Turkey)

  • DBS for a patient with KMT2B-SHANK2 related dystonia

    L. Pan, G. Riboldi, A. Mogilner, C. Toro, S. Frucht (New York, USA)

  • DBS Targeting in a Neuromodulation Monitoring Unit – First 30 cases

    T. Sanger, J. Maclean, A. Tongol, J. Olaya, M. Liker (Orange, USA)

  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley